Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114920775B details novel axial chiral bisindole catalyst synthesis offering high stereoselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN114409714B reveals a palladium-catalyzed route for planar chiral ferrocenes. This method offers high enantioselectivity and scalable manufacturing for global supply chains.
Patent CN111233852A discloses a benzoisofuran-based ligand for asymmetric fluorination, offering mild conditions and high stereoselectivity for pharmaceutical intermediate manufacturing.
Novel nitroxide catalyst enables high-yield azlactone ring opening. Reduces costs in pharmaceutical intermediate manufacturing with superior enantioselectivity.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.
Novel chiral spiro ammonium salt catalyst patent CN115197145B enables high-yield oxy-Cope rearrangement. Delivers superior enantioselectivity and scalable manufacturing for pharmaceutical intermediates.
Novel chiral phosphoric acid catalyzed synthesis of axially chiral indole-naphthalene compounds with high enantioselectivity for pharmaceutical applications.
Novel synthesis method offers high enantioselectivity and cost reduction for asymmetric MBH and cyclization reactions in pharmaceutical manufacturing.
Patent CN112920173A details a mild chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing potential.
Novel bulky chiral quaternary ammonium salt enhances enantioselectivity in olefin oxidation, offering cost-effective solutions for API manufacturing.
Novel synthesis method offers high enantioselectivity and mild conditions for asymmetric reactions, ensuring reliable supply chain and cost efficiency.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN101591250A details a streamlined one-step Mannich synthesis and tartaric acid resolution for high-purity chiral amino alcohol ligands, offering significant cost and supply chain advantages.
Patent CN110452150A reveals a novel chiral phosphoric acid catalyzed synthesis. Delivers high optical purity and cost reduction in fine chemical manufacturing for global supply chains.
Patent CN113087714B discloses a novel Rh(II)-catalyzed N-H insertion method for axial chiral aryl indole carbazoles, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and cost reduction in API manufacturing.
Novel 5 5 tetralone skeleton chiral phosphoric acid patent CN105111228A offers enhanced acidity and enantioselectivity for pharmaceutical intermediates with cost effective synthesis
Novel axial chiral indole-furan catalyst patent CN117720537B enables mild asymmetric synthesis. Offers high enantioselectivity and cost-effective manufacturing for reliable pharma intermediate supply chains.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.